| Literature DB >> 32612281 |
Der-Yen Lee1, Yu-Rung Jiu2, Ching-Liang Hsieh3,4,5.
Abstract
Different point stimulations can induce brain activity in specific regions, and however whether these stimulations affect unique neurotransmitter transmission remains unknown. Therefore, we aimed to investigate the effect of point specificity to the brain by resolving the metabolite profiles. Eighteen Sprague-Dawley rats were randomly divided into three groups: (1) the sham group: sham acupuncture at Zusanli (ST36) without electric stimulation; (2) the Zusanli (ST36) group: electroacupuncture (EA) at ST36; and (3) the Neiguan (PC6) group: EA at PC6. Then, the metabolites from rat brain samples were measured by LC-ESI-MS. The results of a partial least squares discriminant analysis revealed the differences among the sham, ST36, and PC6 groups regarding the relative content of metabolites in the cerebral cortex, hippocampus, and hypothalamus. EA at PC6 resulted in downregulation of adenosine, adrenaline, γ-aminobutyric acid, glycine, and glutamate majorly in hippocampus, and then in cerebral cortex. Otherwise, EA at ST6 resulted in upregulation of adrenaline and arginine in hippocampus, and all stimulations showed barely change of identified neurotransmitters in hypothalamus. These differential metabolite and neurotransmitter profiles prove that brain areas can be modulated by point specificity and may provide a maneuver to understand more details of meridian.Entities:
Mesh:
Substances:
Year: 2020 PMID: 32612281 PMCID: PMC7329888 DOI: 10.1038/s41598-020-67766-0
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1Metabolite signatures of acupoints. (A) Base-peak-ion chromatograms of electroacupuncture in the sham, ST36, and PC6 groups for the cerebral cortex, hippocampus, and hypothalamus, respectively. (B) PLS-DA plot of the cerebral cortex, hippocampus, and hypothalamus of rats presenting the difference of metabolite profiles in the sham, ST36, and PC6 groups.
Summary of acquired signal counts from the integrated chromatogram peak area in the cerebral cortex.
| Peak area (signal counts) | Adenosine | Adrenaline | Arginine | GABA | Glutamate | Glycine |
|---|---|---|---|---|---|---|
| Sham | 8,506 | 12,562 | 1,825,642 | 36,942,871 | 33,059,440 | 21,626,500 |
| ST36 | 5,192 | 16,702 | 1,723,435 | 34,450,560 | 29,231,457 | 21,324,986 |
| PC6 | 3,640 | 10,330 | 1,487,886 | 26,374,864 | 26,862,444 | 15,176,943 |
| Sham RSD (%) | 23.3 | 3.0 | 16.8 | 17.1 | 22.3 | 13.4 |
| ST36 RSD (%) | 17.9 | 19.1 | 16.8 | 8.7 | 10.4 | 10.7 |
| PC6 RSD (%) | 23.7 | 12.3 | 22.7 | 18.4 | 15.4 | 16.9 |
| ST36 versus Sham | 0.00897 | 0.0178 | 0.54215 | 0.31951 | 0.18274 | 0.8175 |
| PC6 versus Sham | 0.0058 | 0.00734 | 0.15344 | 0.04766 | 0.2137 | 0.02532 |
| PC6 versus ST36 | 0.07712 | 0.01816 | 0.67197 | 0.07508 | 0.54096 | 0.05417 |
Figure 2Neurotransmitter changes induced by electroacupuncture at ST36 and PC6. The relative levels of six molecules in the (A) cerebral cortex, (B) hippocampus and (C) hypothalamus were determined by LC–MS analysis. GABA, γ-aminobutyric acid; **p < 0.05; ***p < 0.01.
Summary of acquired signal counts from the integrated chromatogram peak area in the hippocampus.
| Peak area (signal counts) | Adenosine | Adrenaline | Arginine | GABA | Glutamate | Glycine |
|---|---|---|---|---|---|---|
| Sham | 16,610 | 275,884 | 2,249,246 | 5,573,497 | 5,869,623 | 7,692,728 |
| ST36 | 14,344 | 367,814 | 2,952,275 | 5,485,762 | 5,457,317 | 9,060,471 |
| PC6 | 13,859 | 267,383 | 2,027,722 | 4,777,837 | 4,669,993 | 5,411,060 |
| Sham RSD (%) | 20.7 | 21.8 | 8.4 | 10.5 | 8.5 | 12.9 |
| ST36 RSD (%) | 28.6 | 12.4 | 13.8 | 8.0 | 5.2 | 14.0 |
| PC6 RSD (%) | 11.5 | 21.7 | 13.8 | 6.3 | 4.4 | 11.7 |
| ST36 versus Sham | 0.31763 | 0.01169 | 0.00972 | 0.65919 | 0.12033 | 0.01361 |
| PC6 versus Sham | 0.03762 | 0.62355 | 0.0744 | 0.01746 | 0.00063 | 0.00327 |
| PC6 versus ST36 | 0.80332 | 0.02465 | 0.00183 | 0.02681 | 0.00215 | 0.00268 |
Summary of acquired signal counts from the integrated chromatogram peak area in the hypothalamus.
| Peak area (signal counts) | Adenosine | Adrenaline | Arginine | GABA | Glutamate | Glycine |
|---|---|---|---|---|---|---|
| Sham | 6,422 | 28,119 | 516,814 | 798,703 | 157,116 | 1,384,941 |
| ST36 | 5,509 | 23,656 | 410,340 | 701,097 | 112,830 | 1,147,739 |
| PC6 | 4,173 | 40,450 | 493,100 | 668,345 | 127,710 | 1,177,702 |
| Sham RSD (%) | 110.5 | 26.9 | 9.0 | 18.6 | 8.3 | 8.6 |
| ST36 RSD (%) | 113.5 | 27.4 | 23.0 | 12.3 | 19.2 | 14.4 |
| PC6 RSD (%) | 38.0 | 31.1 | 30.7 | 32.0 | 39.8 | 25.9 |
| ST36 versus Sham | 0.10479 | 0.21463 | 0.07938 | 0.11025 | 0.0201 | 0.01504 |
| PC6 versus Sham | 0.50662 | 0.04063 | 0.73616 | 0.1724 | 0.22437 | 0.22313 |
| PC6 versus ST36 | 0.65114 | 0.00342 | 0.36351 | 0.62593 | 0.52444 | 0.80948 |
Figure 3The summary of differential effects on the putative meridian paths between ST36 and PC6. The linkage of dash line implies the potential role of hypothalamus in coordinating modulation of metabolic change in cerebral cortex or hippocampus by referring the previous studies[31,32].